• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.84% Nasdaq Down 1.04%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    2.45 Down 0.07(2.78%) 2:29PM EDT
    Prev Close:2.52
    Open:2.50
    Bid:2.44 x 100
    Ask:2.54 x 100
    1y Target Est:12.80
    Beta:1.1669
    Earnings Date:May 10 - May 16 (Est.)
    Day's Range:2.41 - 2.54
    52wk Range:1.69 - 5.84
    Volume:18,510
    Avg Vol (3m):38,273
    Market Cap:17.11M
    P/E (ttm):N/A
    EPS (ttm):-2.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXADown 2.78%17.11M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.05
    Quarterly EPS Est (Mar-16) :-0.35
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback